Lieber


Harvard and the Fight for Foreign Collaboration

Debate over the regulation of foreign money in academia, once an afterthought, has become a microcosm of the U.S.’s attempts to remain the world’s top innovator, exposing a tension between the government’s efforts to remain competitive and academia’s goals to promote innovation and the free flow of ideas.


Lieber Attorneys Petition District Court Judge for New Trial or Acquittal

Attorneys for Harvard professor Charles M. Lieber argued in court on Thursday that the renowned chemist’s December conviction should be overturned, alleging that the government failed to sufficiently prove its case.


Justice Department to End China Initiative, which Brought Down Lieber

The United States Department of Justice on Wednesday shuttered its controversial China Initiative, an anti-espionage crackdown that ensnared a top Harvard faculty member last year.


Bacow Defends Foreign Research Collaboration Following Lieber's Conviction

University President Lawrence S. Bacow reiterated in a Thursday interview Harvard’s commitment to academic collaboration with foreign scholars following the federal conviction of Chemistry professor Charles M. Lieber.


Following Charles Lieber’s Conviction, ‘Shock’ and Sadness Linger Among His Harvard Colleagues

Following Chemistry professor Charles M. Lieber’s conviction last month, Harvard scientists say they are “shocked” and “saddened” about the prolific research chemist's fall from grace — and apprehensive about the future of international scientific collaboration.


Ten Stories That Shaped 2021

At Harvard, 2021 was a year marked by change. The school’s long-awaited return to in-person operations injected new life into a campus that had been left dormant for over a year by Covid-19. And in an unexpected shift, the University announced its intention to divest its endowment from fossil fuels after a decade of public pressure. Separately, faculty controversies — including a federal conviction and a high-profile departure — ignited debates that rippled across academia. Below, The Crimson looks back at the 10 stories that shaped the last year at Harvard.


In Day 5 of Trial, Investigators Say Lieber’s Alleged False Statements Impeded Federal Inquiries

Federal officials testified in court Monday that alleged false statements made by Harvard professor Charles M. Lieber prevented government authorities from fully exploring his ties to China.


Lieber Told FBI He ‘Wasn’t Completely Transparent’ in Prior Interview with Federal Investigators

Harvard professor Charles M. Lieber told the FBI in January 2020 that he “wasn’t completely transparent” in a separate interview with federal investigators two years prior, according to video of an interrogation presented in court by government prosecutors on Friday.


Attorneys Spar Over Documents Recovered in FBI Raids During Third Day of Lieber Trial

Defense attorneys representing Harvard professor Charles M. Lieber, who is facing trial for allegedly lying to federal investigators about his ties to China, sparred with prosecutors on Thursday over the evidentiary relevance of documents obtained during raids of the prominent chemist’s home and office.


DAY 1

Former Harvard Chemistry chair Charles M. Lieber (left) and his lawyer, Marc Mukasey, exit the John J. Moakley United States Courthouse in Boston on Tuesday.


As Trial Begins, Lawyers for Harvard Professor Charles Lieber Say He Did Not Conceal Ties to China

Lawyers for Harvard professor Charles M. Lieber, who is accused of lying to federal investigators about his ties to China, mounted a dramatic defense of the renowned chemist in federal court Wednesday, calling the government’s proof against him “mangled” and “misguided.”


Experts Say Lieber Trial Could Decide Fate of DOJ’s China Initiative

As former Harvard Chemistry chair Charles M. Lieber goes on trial on federal charges beginning Tuesday, law and trade experts speculated that his case’s outcome could decide the fate of the Department of Justice’s China Initiative.


1-16 of 16